Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125268751 | 12526875 | 1 | I | 20160623 | 20160705 | 20160705 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-052496 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 99.77000 | KG | 20160705 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125268751 | 12526875 | 1 | PS | ORENCIA | ABATACEPT | 1 | Subcutaneous | UNK | U | AAD5184 | 125118 | SOLUTION FOR INJECTION | |||||||
| 125268751 | 12526875 | 2 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Unknown | UNK, QMO | U | 0 | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125268751 | 12526875 | 1 | Rheumatoid arthritis |
| 125268751 | 12526875 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125268751 | 12526875 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125268751 | 12526875 | Cellulitis | |
| 125268751 | 12526875 | Mass | |
| 125268751 | 12526875 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |